European Stocks Struggle for Direction as Oil Prices Edge Forward Ahead of Inventory Projections

European Stocks Struggle for Direction as Oil Prices Edge Forward Ahead of Inventory Projections

European equity benchmarks were struggling for direction on Wednesday morning as oil prices advanced ahead of a weekly US inventory forecast, investors digested the wording in a highly anticipated speech from the leader of Spain’s Catalonia region and manufacturers showed mixed fortunes. Oil prices were edging higher in recent trade ahead of the release of the American Petroleum Institute’s weekly US stockpile forecast. West Texas Intermediate crude oil futures, the […]

Read More ˃
Nikkei 225 Up 0.28% On Wall Street Cues

Nikkei 225 Up 0.28% On Wall Street Cues

The Nikkei 225 opened slightly lower Wednesday but gained through morning and afternoon sessions, to finish up 0.28% near a 21-year high. Traders took heart on Wall Street cues, and a report from the International Monetary Fund that global growth will track at 3.6% in 2017. Corporate profits in Japan have been strong on exports, and investors are not shedding shares before earnings season. In other news, Japan machinery orders […]

Read More ˃
Boeing Agrees to Acquire Aurora Flight Sciences

Boeing Agrees to Acquire Aurora Flight Sciences

Boeing (BA) said pre-market Thursday it plans to acquire Aurora Flight Sciences, a maker of advanced aerospace platforms. Terms of the agreement weren’t disclosed. Aurora specializes in autonomous systems technologies to enable advanced robotic aircraft for future aerospace applications and vehicles. It has designed, produced and flown more than 30 unmanned air vehicles since the company was founded in 1989. During the last decade, Aurora has collaborated with Boeing on […]

Read More ˃
TG Therapeutics Advances Anti-PD-LI Monoclonal Antibody Study

TG Therapeutics Advances Anti-PD-LI Monoclonal Antibody Study

TG Therapeutics (TGTX) said Thursday it has advanced the clinical trial of anti-PD-L1 monoclonal antibody with the dosing of its first patient. The study will evaluate the safety and tolerability of ascending doses of the antibody in patients with selected recurrent or metastatic cancers. Secondary endpoints for this study include the evaluation or characterization of the pharmacokinetics, immunogenicity and preliminary efficacy. This study will initially enroll patients in sites across […]

Read More ˃
Brookfield Infrastructure Partners To Commence $1 Bln Equity Offering

Brookfield Infrastructure Partners To Commence $1 Bln Equity Offering

Brookfield Infrastructure Partners LP (BIP) said Monday that it has agreed to issue 16.6 million units on a bought deal basis, to a syndicate of underwriters co-led by RBC Capital Markets, TD Securities Inc., Citigroup, BofA Merrill Lynch and HSBC at a price of $42.10 per unit for gross proceeds of $700 million. Also, Brookfield Asset Management Inc. (BAM) and certain of its related entities will purchase 7.4 million redeemable […]

Read More ˃